PHR1349
β-Alanin
Pharmaceutical Secondary Standard; Certified Reference Material
Synonym(e):
β-Ala, 3-Aminopropionsäure
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
Lineare Formel:
NH2CH2CH2COOH
CAS-Nummer:
Molekulargewicht:
89.09
Beilstein:
906793
EG-Nummer:
MDL-Nummer:
UNSPSC-Code:
41116107
PubChem Substanz-ID:
NACRES:
NA.24
Empfohlene Produkte
Qualität
certified reference material
pharmaceutical secondary standard
Qualitätsniveau
Agentur
traceable to USP 1012495
API-Familie
beta-alanine
Analysenzertifikat (CofA)
current certificate can be downloaded
Methode(n)
HPLC: suitable
gas chromatography (GC): suitable
mp (Schmelzpunkt)
202 °C (dec.) (lit.)
Anwendung(en)
pharmaceutical (small molecule)
Format
neat
Lagertemp.
2-30°C
SMILES String
NCCC(O)=O
InChI
1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)
InChIKey
UCMIRNVEIXFBKS-UHFFFAOYSA-N
Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich
Allgemeine Beschreibung
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Beta Alanine is a non-protein amino acid, widely available in plants as one of the precursors for the essential vitamin, pantothenate. It exhibits behavior of an osmoprotectant in microbial assays. It is also the precursor for beta-alanine betaine in the plant family Plumbaginaceae.
Anwendung
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Biochem./physiol. Wirkung
Diese endogene β-Aminosäure ist ein unselektiver Agonist von Glycin-Rezeptoren und ein Ligand des G-Protein-gekoppelten Orphan Rezeptors TGR7 (MrgD). Der β-Alaninfluss spielt eine zellschützende Rolle indem er die osmotische Stabilität von Meeresorganismen, preimplantation-Mausembryos und Säugerzellen unter hypoxischem Stress stabilisiert.
Hinweis zur Analyse
These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.
Sonstige Hinweise
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
Fußnote
To see an example of a Certificate of Analysis for this material enter LRAC3952 in the slot below. This is an example certificate only and may not be the lot that you receive.
Lagerklassenschlüssel
13 - Non Combustible Solids
WGK
WGK 1
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Choose from one of the most recent versions:
Analysenzertifikate (COA)
Lot/Batch Number
Don't see the Right Version?
If you require a particular version, you can look up a specific certificate by the Lot or Batch number.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Kunden haben sich ebenfalls angesehen
Physiology and Molecular Biology of Stress Tolerance in Plants (2006)
K E Tiedje et al.
Neurochemistry international, 57(3), 177-188 (2010-06-15)
This review discusses the role of beta-alanine as a neurotransmitter. Beta-alanine is structurally intermediate between alpha-amino acid (glycine, glutamate) and gamma-amino acid (GABA) neurotransmitters. In general, beta-alanine satisfies a number of the prerequisite classical criteria for being a neurotransmitter: beta-alanine
Partha Sardar et al.
The American journal of cardiology, 113(7), 1173-1177 (2014-02-12)
Dabigatran is a novel oral anticoagulant and may be useful during atrial fibrillation (AF) ablation for prevention of thromboembolic events. However, the benefits and adverse effects of periprocedural dabigatran therapy have not been thoroughly evaluated. A meta-analysis was performed to
Torben Bjerregaard Larsen et al.
The American journal of medicine, 127(7), 650-656 (2014-02-18)
The bleeding risk among patients with atrial fibrillation is higher early after initiating therapy with vitamin K antagonists (VKAs). Evidence is limited on how prior VKA experience affects bleeding risk when initiating novel oral anticoagulant therapy. We investigated this among
Partha Sardar et al.
The Canadian journal of cardiology, 30(8), 888-897 (2014-07-30)
Recent reports suggest altered antithrombotic efficacy and higher risk of bleeding with new oral anticoagulants (NOACs) in patients with renal insufficiency. A meta-analysis was performed to evaluate the efficacy and safety with recommended doses of NOAC compared with conventional treatment
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.